Article Information
History
- November 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jonathon W. Senefeld, PhD1,
- Stephen A. Klassen, PhD1,
- Shane K. Ford, BS1,
- Chad C. Wiggins, PhD1,
- Bruce C. Bostrom, MD2,
- Michael A. Thompson, MD, PhD3,
- Sarah E. Baker, PhD1,
- Wayne T. Nicholson, MD1,
- Patrick W. Johnson, BS4,
- Rickey E. Carter, PhD4,
- Jeffrey P. Henderson, MD, PhD5,
- William R. Hartman, MD6,
- Liise-anne Pirofski, MD7,
- R. Scott Wright, MD8,
- DeLisa Fairweather, PhD9,
- Katelyn A. Bruno, PhD9,
- Nigel S. Paneth, MD10,
- Arturo Casadevall, MD, PhD11 and
- Michael J. Joyner, MD1,*
- 1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota
- 2Pediatric Oncology & Hematology, Children’s Hospital of Minnesota, Minneapolis, Minnesota
- 3Aurora Cancer Care, Advocate Aurora Health, Milwaukee, Wisconsin
- 4Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida
- 5Department of Medicine and Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
- 6Department of Anesthesiology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin
- 7Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York
- 8Department of Cardiovascular Medicine and Director Human Research Protection Program, Mayo Clinic, Rochester, Minnesota
- 9Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida
- 10Department of Epidemiology and Biostatistics and Department of Pediatrics and Human Development, Michigan State University, East Lansing, Michigan
- 11Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
- ↵* Corresponding author; email: joyner.michael{at}mayo.edu
Posted November 10, 2020.
Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency
